Health
FDA approves marketing of first AI-based device to assist clinicians during colon cancer screening – News-Medical.net
Today, the U.S. Food and Drug Administration authorized marketing of the GI Genius, the first device that uses artificial intelligence (AI) based on machine learning…
Today, the U.S. Food and Drug Administration authorized marketing of the GI Genius, the first device that uses artificial intelligence (AI) based on machine learning to assist clinicians in detecting lesions (such as polyps or suspected tumors) in the colon in real time during a colonoscopy.
Artificial intelligence has the potential to transform health care to better assist health care providers and improve patient care. When AI is combined with traditional screenings or surveillance methods, it…
-
General22 hours agoa pivotal moment in Liberal power struggle
-
Noosa News22 hours agoTayla Harris stars as Melbourne defeats Essendon by 14 points
-
General20 hours agoRussia launches its biggest attack on Ukraine’s gas network since war began on the eve of winter
-
Noosa News16 hours ago28 years later: Grim reality for single house hunters revealed